Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies

During the current coronavirus disease 2019 (COVID-19) pandemic, symptoms of depression are commonly documented among both symptomatic and asymptomatic quarantined COVID-19 patients. Despite that many of the FDA-approved drugs have been showed anti-SARS-CoV-2 activity in vitro and remarkable efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutkat, Omnia, Moatasim, Yassmin, Al‐Karmalawy, Ahmed A., Abulkhair, Hamada S., Gomaa, Mokhtar R., El-Taweel, Ahmed N., Abo Shama, Noura M., GabAllah, Mohamed, Mahmoud, Dina B., Kayali, Ghazi, Ali, Mohamed A., Kandeil, Ahmed, Mostafa, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331004/
https://www.ncbi.nlm.nih.gov/pubmed/35902647
http://dx.doi.org/10.1038/s41598-022-17082-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331004/
https://www.ncbi.nlm.nih.gov/pubmed/35902647
http://dx.doi.org/10.1038/s41598-022-17082-6

Ejemplares similares